BioSpace News Archive

BrickBio, the leading company in site-specific bioconjugation for improved therapeutics, has signed a deal with a large pharmaceutical partner to co-develop a therapeutic antibody drug conjugate (ADC).

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Ilan Ganot, Chief Executive Officer, President and Co-Founder, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 8:20 am ET. Following the prepared remarks, several members of the leadership team will be available for Q&A.

CVS Health is now administering COVID-19 vaccines in skilled nursing facilities in 49 states, with the rollout beginning in 36 states and Washington, D.C. last week.

BioSpace, Inc., the leading life sciences news and careers site, has announced their 25 selections for biopharma’s most promising up-and-coming companies in 2021.

The global animal blood plasma products and derivatives market is has a fragmented vendor landscape due to the presence of several players, Transparency Market Research observes.

TMR observes that the global transdermal scopolamine market is experiencing the high competition and consolidation due to presence of strong players.

Accuray Incorporated announced its participation in the 39th J.P. Morgan Annual Healthcare Conference.

Partnership aims to pioneer breakthroughs in post-quantum cryptography and neuromorphic computing, leading to effective research outcomes and a knowledge-driven ecosystem in Abu Dhabi and the UAE

RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases

A world-first, AI powered, outcomes-driven, decision support tool – EchoGo Pro, has been cleared by the FDA and is now available to clinicians across the U.S. EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for Coronary Artery Disease (CAD), the most common form of heart disease and leading cause of death in the U.S.